Mechanistic and therapeutic advances in rare skeletal disease
Ended Project Grant Awarded Last action
- Award ID
- R13AR074876
- Recipient
-
Osteogenesis Imperfecta Foundation Inc. UEI FCRBULN8P2M6
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $35,000
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- Place of performance
- Gaithersburg, MD 20878, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | -$2,000 | |
| Amendment | $2,000 | |
| Amendment | $2,000 | |
| Amendment | $30,000 | |
| Original award | $3,000 |
Quick answers
Who received award R13AR074876?
R13AR074876 was awarded to Osteogenesis Imperfecta Foundation Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 1, 2018.
How much is award R13AR074876 worth?
$35,000 has been obligated on R13AR074876.
Which agency awarded R13AR074876?
National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) awarded R13AR074876, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award